WO2009024707A3 - Utilisation d'un extrait de radamaea montana pour la preparation d'une composition cosmetique - Google Patents

Utilisation d'un extrait de radamaea montana pour la preparation d'une composition cosmetique Download PDF

Info

Publication number
WO2009024707A3
WO2009024707A3 PCT/FR2008/051417 FR2008051417W WO2009024707A3 WO 2009024707 A3 WO2009024707 A3 WO 2009024707A3 FR 2008051417 W FR2008051417 W FR 2008051417W WO 2009024707 A3 WO2009024707 A3 WO 2009024707A3
Authority
WO
WIPO (PCT)
Prior art keywords
radamea
preparing
cosmetic composition
montana extract
montana
Prior art date
Application number
PCT/FR2008/051417
Other languages
English (en)
Other versions
WO2009024707A2 (fr
Inventor
Gilles Comte
Cedric Bertrand
Roukia Djoudi
Zafera Antoine Rabesa
Original Assignee
Univ Claude Bernard Lyon
Centre Nat Rech Scient
Gilles Comte
Cedric Bertrand
Roukia Djoudi
Zafera Antoine Rabesa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Claude Bernard Lyon, Centre Nat Rech Scient, Gilles Comte, Cedric Bertrand, Roukia Djoudi, Zafera Antoine Rabesa filed Critical Univ Claude Bernard Lyon
Publication of WO2009024707A2 publication Critical patent/WO2009024707A2/fr
Publication of WO2009024707A3 publication Critical patent/WO2009024707A3/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/46Unsaturated compounds containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne l'utilisation d'un extrait de Radamaea montana pour la préparation d'une composition cosmétique, dermatologique ou pharmaceutique, l'extrait de Radamaea montana étant utilisé en tant qu'agent anti-oxydant.
PCT/FR2008/051417 2007-07-30 2008-07-28 Utilisation d'un extrait de radamaea montana pour la preparation d'une composition cosmetique WO2009024707A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0756812A FR2919605B1 (fr) 2007-07-30 2007-07-30 Utilisation d'un extrait de radamaea montana pour la preparation d'une composition cosmetique
FR0756812 2007-07-30

Publications (2)

Publication Number Publication Date
WO2009024707A2 WO2009024707A2 (fr) 2009-02-26
WO2009024707A3 true WO2009024707A3 (fr) 2009-07-16

Family

ID=39099629

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/051417 WO2009024707A2 (fr) 2007-07-30 2008-07-28 Utilisation d'un extrait de radamaea montana pour la preparation d'une composition cosmetique

Country Status (2)

Country Link
FR (1) FR2919605B1 (fr)
WO (1) WO2009024707A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102590367A (zh) * 2011-01-07 2012-07-18 昆明制药集团股份有限公司 一种检测芒果苷元产品的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1541158A1 (fr) * 2003-12-04 2005-06-15 Cognis Deutschland GmbH & Co. KG Composition antioxydante pour l'administration orale ou topique

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1541158A1 (fr) * 2003-12-04 2005-06-15 Cognis Deutschland GmbH & Co. KG Composition antioxydante pour l'administration orale ou topique

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BORN, M. ET AL.: "Electrochemical behaviour and antioxidant acitivity of some natural polyphenols", HELVETICA CHIMICA ACTA, vol. 79, 1996, pages 1147 - 1158, XP002470662 *
ESCHENMOSER, WALTER ET AL: "Synthesis of (+)-(5S,6S)-azafrin methyl ester; absolute configuration of aeginetic acid and of further vicinal apocarotenediols", HELVETICA CHIMICA ACTA , 65(1), 353-64 CODEN: HCACAV; ISSN: 0018-019X, 1982, XP002470680 *
KUBO, I. ET AL.: "Flavonols from heterotheca inuloides: tyrosinase inhibitory activity and structural criteria", BIOORGANIC AND MEDICINAL CHEMISTRY, vol. 8, 2000, pages 1749 - 1755, XP002470663 *
MASUOKA, CHIKAKO ET AL: "Antioxidative, antihyaluronidase and antityrosinase activities of some constituents from the aerial part of piper elongatum VAHL", FOOD SCIENCE AND TECHNOLOGY RESEARCH , 9(2), 197-201 CODEN: FSTRFS; ISSN: 1344-6606, 2003, XP002470659 *
MONTORO, P. ET AL.: "Studies of the constituents of cyclanthera pedata fruits: isolation and structure elucidation of new flavonoid glycosides and their antioxidant activity", J. AGRIC. FOOD CHEM., vol. 11, 2001, pages 5156 - 5160, XP002470661 *
PICERNO, P. ET AL.: "Phenolic constituents and antioxidant properties of xanthosoma violaceum leaves", J. AGRIC. FOOD CHEM., vol. 51, 2003, pages 6423 - 6428, XP002470660 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102590367A (zh) * 2011-01-07 2012-07-18 昆明制药集团股份有限公司 一种检测芒果苷元产品的方法

Also Published As

Publication number Publication date
FR2919605A1 (fr) 2009-02-06
FR2919605B1 (fr) 2009-11-20
WO2009024707A2 (fr) 2009-02-26

Similar Documents

Publication Publication Date Title
WO2011077043A3 (fr) Derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
WO2009074735A3 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2010069532A8 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
WO2009118107A3 (fr) Composition d'un produit de soins cutanés
WO2011148328A3 (fr) Procédé cosmétique pour le maquillage et/ou le soin de la peau et/ou des lèvres
WO2008132229A3 (fr) Solutions et compositions hautement concentrées en insuline
WO2009012871A3 (fr) Capsule filtrant les uv
CR10305A (es) "derivados sustituidos de cromanol y su uso.
WO2011122869A3 (fr) Composition cosmétique comprenant du coumestrol ou un extrait de fèves contenant du coumestrol, pour les soins de la peau
MX2013005995A (es) Composicion topica que promueve la melanina.
WO2009007532A3 (fr) Utilisation d'une hemoglobine pour la preparation de pansements, et pansements ainsi prepares
WO2007130822A3 (fr) Modulateurs des récepteurs mglur5 iii
WO2007144521A3 (fr) Composition cosmetique a usage topique comprenant du wasabi
WO2009024374A3 (fr) Formulations contenant de nouveaux composés dipolaires ioniques et leur utilisation
WO2012075015A3 (fr) Compositions pharmaceutiques orales de métronidazole
WO2009047443A3 (fr) Composition cosmétique destinée à améliorer l'état de la peau
WO2010046061A3 (fr) Préparations cosmétiques et/ou pharmaceutiques
WO2007083190A3 (fr) Extrait d'helychrisum insoluble dans l'eau, et procédés d'élaboration et d'utilisation correspondants
WO2009027382A3 (fr) Composition pulvérisable contenant de l'extrait de feuille de vigne rouge
MX2011006721A (es) Formulacion farmaceutica de fenofibrato nanonizado.
WO2008098143A3 (fr) Composés antimicrobiens et leurs procédés d'utilisation
WO2011026577A3 (fr) Préparations dotées d'amines polymères non hydrosolubles pour réduire des odeurs corporelles
WO2010130776A3 (fr) Utilisation de delta-tocophéryl-carbohydrate en tant qu'agent de dépigmentation
WO2008125771A3 (fr) Utilisation cosmetique d'un extrait de debaryomyces hansenii
BRPI0810960A2 (pt) "composto, composição farmacêutica, composição cosmética e usos de um composto e de uma composição".

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08827957

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2010518721

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: JP

122 Ep: pct application non-entry in european phase

Ref document number: 08827957

Country of ref document: EP

Kind code of ref document: A2